Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon B Dimmitt

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
British Journal of Clinical Pharmacology|February 3, 2018
The pharmacodynamic and clinical trial evidence for statin doseSimon B Dimmitt, Hans G Stampfer, John B Warren
The Medical Journal of Australia|April 16, 2013
The role of depression in the primary prevention of cardiovascular diseaseHans G Stampfer, Dana A Hince, Simon B Dimmitt
British Journal of Clinical Pharmacology|June 11, 2014
β-adrenoceptor blockers valuable but higher doses not necessarySimon B Dimmitt, Hans G Stampfer, John B Warren
Journal of the American College of Cardiology|August 15, 2020
Small Increase in Mortality With High Dose, But Not Low Dose, StatinSimon B Dimmitt, John B Warren, Hans G Stampfer
British Journal of Clinical Pharmacology|July 6, 2019
Optimising low-dose methotrexate for rheumatoid arthritis-A reviewCatherine J Lucas, Simon B Dimmitt, Jennifer H Martin
Lancet (London, England)|March 22, 2017
Safety and efficacy of statinsSimon B Dimmitt, Hans G Stampfer, Jennifer H Martin
British Journal of Clinical Pharmacology|April 5, 2016
Cholesterol trials and mortalityJohn B Warren, Simon B Dimmitt, Hans G Stampfer
British Journal of Clinical Pharmacology|May 4, 2019
Antithrombotic dose: Some observations from published clinical trialsSimon B Dimmitt, Christopher N Floyd, Robin E Ferner
British Journal of Clinical Pharmacology|June 21, 2019
Why maximum tolerated dose?Hans G Stampfer, Genevieve M Gabb, Simon B Dimmitt
British Journal of Clinical Pharmacology|January 24, 2015
Common statin side effects explain poor complianceSimon B Dimmitt, Hans G Stampfer, John B Warren
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
British Journal of Clinical Pharmacology|February 3, 2018
The pharmacodynamic and clinical trial evidence for statin doseSimon B Dimmitt, Hans G Stampfer, John B Warren
The Medical Journal of Australia|April 16, 2013
The role of depression in the primary prevention of cardiovascular diseaseHans G Stampfer, Dana A Hince, Simon B Dimmitt
British Journal of Clinical Pharmacology|June 11, 2014
β-adrenoceptor blockers valuable but higher doses not necessarySimon B Dimmitt, Hans G Stampfer, John B Warren
Journal of the American College of Cardiology|August 15, 2020
Small Increase in Mortality With High Dose, But Not Low Dose, StatinSimon B Dimmitt, John B Warren, Hans G Stampfer
British Journal of Clinical Pharmacology|July 6, 2019
Optimising low-dose methotrexate for rheumatoid arthritis-A reviewCatherine J Lucas, Simon B Dimmitt, Jennifer H Martin
Lancet (London, England)|March 22, 2017
Safety and efficacy of statinsSimon B Dimmitt, Hans G Stampfer, Jennifer H Martin
British Journal of Clinical Pharmacology|April 5, 2016
Cholesterol trials and mortalityJohn B Warren, Simon B Dimmitt, Hans G Stampfer
British Journal of Clinical Pharmacology|May 4, 2019
Antithrombotic dose: Some observations from published clinical trialsSimon B Dimmitt, Christopher N Floyd, Robin E Ferner
British Journal of Clinical Pharmacology|June 21, 2019
Why maximum tolerated dose?Hans G Stampfer, Genevieve M Gabb, Simon B Dimmitt
British Journal of Clinical Pharmacology|January 24, 2015
Common statin side effects explain poor complianceSimon B Dimmitt, Hans G Stampfer, John B Warren
Pageof 3